Max Scherzer placed on 15-day IL with back spasms, Chad Dallas recalled

What happened

The Blue Jays announced that Max Scherzer is heading back to the injured list — this time with back spasms, retroactive to June 14 — and recalled right-hander Chad Dallas in the corresponding roster move. Scherzer had been scheduled to start for Toronto but will not take the ball, per the club's announcement.

The placement is on the 15-day IL, the standard designation for pitchers under league rules, meaning he cannot be activated before the retroactive date has run its course. The Blue Jays have not indicated whether a transfer to the 60-day IL — which would free a 40-man roster spot — is under consideration.

Why it matters

This is Scherzer's second IL stint of the season, and the third distinct ailment to interrupt his 2026 campaign. MLB Trade Rumors reported that he spent roughly six weeks on the injured list from late April into early June dealing with right forearm tendinitis and left ankle inflammation. He came back, made one start, was lined up for a second — and now back spasms have returned him to the shelf before that start could happen.

For a rotation already navigating a 79-83 record and elimination from both the AL East division race and the Wild Card race, absorbing a third health interruption from the same pitcher in the same season is the kind of operational problem that compounds quietly. The Blue Jays sit 19 games back in the division and rank sixth relative to the Wild Card cut line, 5.0 games out. The margin for error that might have made each absence feel urgent has largely dissolved; what remains is the question of what the organization gets from Scherzer for the rest of the year, if anything.

Chad Dallas steps into the vacated roster spot. His recall is the direct operational consequence of the move, though MLB Trade Rumors does not specify what role he will fill in the short term.

The numbers

The season line tells the story plainly. In six starts, Scherzer has thrown 22 innings and allowed 25 earned runs, per MLB Trade Rumors. That is a rate difficult to defend in any context, let alone for a future Hall-of-Famer in the final chapter of a career built on sustained dominance.

The peripheral numbers are equally stark. His 10.8% walk rate sits above the league average and is on pace to be the worst of his career, per MLB Trade Rumors. His 13.7% strikeout rate is well below average and, also per MLB Trade Rumors, a career worst. For a pitcher whose calling card across two decades has been elite bat-missing paired with exceptional command, those two numbers arriving simultaneously — and at career-worst levels — represent a meaningful departure from the profile that defined him.

MLB Trade Rumors described the results as "suboptimal, to put it politely." That is a generous framing, and the desk will not argue with it.

Where the club stands

Toronto enters Wednesday sitting at 79-83, fifth in the AL East, riding a one-game winning streak. The Blue Jays are eliminated from the division race and eliminated from the Wild Card race.

The upcoming schedule offers no particular relief. Wednesday brings a trip to Fenway Park, where Braydon Fisher is the probable starter against Boston's Jake Bennett. Thursday, also at Fenway, lines up Trey Yesavage against Sonny Gray. The series then shifts to Wrigley Field on Friday, where Kevin Gausman is slated to face Ben Brown of the Cubs.

None of those three scheduled starters is Scherzer, which means the immediate rotation impact of his IL placement is absorbed elsewhere. The broader question — what the back of a 79-83 roster looks like when its most decorated arm has made six starts and thrown 22 innings — is one the Blue Jays front office is working through in real time.

What we don't know yet

MLB Trade Rumors was candid about the limits of what is currently known. The outlet noted that the severity of the back spasms is unclear, while also characterizing the issue as presumably not major — a hedge worth preserving, because back problems in pitchers have a way of defying early optimism. That characterization belongs to the report, not to any official club communication.

No timetable has been attached to this IL stint beyond the minimum implied by the placement. There is no indication of whether Scherzer will require imaging, a rehab assignment, or any further evaluation. The Blue Jays have not, per MLB Trade Rumors, offered a prognosis or a target return window.

What to watch

The most immediate question is whether the back spasms resolve quickly enough for Scherzer to contribute again before the season ends, or whether this placement effectively closes out his 2026. Given that he already missed roughly six weeks with two separate issues and returned to make only one start before this new problem emerged, the pattern warrants attention even if the current diagnosis sounds routine.

Chad Dallas's role in the rotation or bullpen over the coming days is worth monitoring, as is any further roster movement if the Blue Jays decide the placement needs to be extended or converted. Under general league rules, a pitcher on the 15-day IL can be transferred to the 60-day IL at any point, which would affect 40-man roster construction — though no such move has been reported.

For a team already outside the playoff picture, the calculus around Scherzer's usage for the remainder of the season is less about October and more about what the organization learns, and what he can still offer, in the innings that remain.